OSCR
Oscar Health, Inc.
OSCR's fundamentals are strong: revenue grew 55% and its operating margin went from −1.9% to 5.4%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
TRIB
Trinity Biotech plc
There isn't enough reported data to score TRIB yet.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
TRIB Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Weak |
TRIB's revenue, profitability, cash flow and balance sheet are all currently under pressure.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
TRIB PE Valuation
TRIB has no meaningful PE right now: it lost money over the past year.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
TRIB Forward outlook
There aren't enough analyst estimates for TRIB to show an outlook.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the stronger earnings trend. Trailing diluted EPS is up 147% for OSCR versus TRIB down 174%.
TRIB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$60.60 | +$21.54 |
| Q3 2025 | -$68.28 | -$0.42 |
| Q2 2025 | -$73.86 | +$6.60 |
| Q1 2025 | -$85.44 | -$2.88 |
| Q4 2024 | -$82.14 | +$14.16 |
| Q3 2024 | -$67.86 | +$46.44 |
| Q2 2024 | -$80.46 | +$42.54 |
| Q1 2024 | -$82.56 | +$113.04 |
TRIB is still losing money, but far less than before: $60.60 per share over the past year, against $195.60 at its worst in early 2023.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the stronger quarterly revenue trend. Revenue is up 72% for OSCR versus down 30% for TRIB.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR's operating margin was 3.5% last quarter, up 7.8 points from the same quarter a year ago.
TRIB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $11.1M | -30% |
| Q3 2025 | $14.2M | -6% |
| Q2 2025 | $11M | -31% |
| Q1 2025 | $7.6M | -48% |
| Q4 2024 | $15.9M | +18% |
| Q3 2024 | $15.2M | +3.2% |
| Q2 2024 | $15.8M | +14% |
| Q1 2024 | $14.7M | -0.8% |
TRIB's revenue has slid since its 2020 peak: $11M last quarter, down 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -27% | +46 points |
| Q3 2025 | -3.8% | +13 points |
| Q2 2025 | -28% | -2.2 points |
| Q1 2025 | -62% | -42 points |
| Q4 2024 | -73% | -47 points |
| Q3 2024 | -17% | +14 points |
| Q2 2024 | -26% | +81 points |
| Q1 2024 | -21% | +5.8 points |
TRIB's operating margin was −27% last quarter, up 46 points from the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the stronger cash trend. Its trailing FCF is up 545% versus its history, compared with TRIB at up 4.7%.
TRIB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.5M | -351% |
| Q3 2025 | -$77.1K | +$6.2M |
| Q2 2025 | -$1.7M | +$2.6M |
| Q1 2025 | -$3M | +$3.3M |
| Q4 2024 | $615K | +$2.5M |
| Q3 2024 | -$6.3M | -$1M |
| Q2 2024 | -$4.3M | +$715K |
| Q1 2024 | -$6.3M | -$2.9M |
TRIB has burned cash in most quarters: −$6M over the past year, against −$16M the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
TRIB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -950 shares |
| 1 year | +31% | +148K shares |
| 3 years | +144% | +367K shares |
| 5 years | +249% | +443K shares |
| Available history | +266% | +451K shares |
TRIB has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $270,000 |
| Q1 2024 | — |
TRIB hasn't bought back shares in the past year.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
TRIB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2022 | 12.0x | High |
| Q4 2021 | 7.5x | High |
| Q3 2021 | 16.9x | High |
| Q2 2021 | 5.2x | High |
| Q1 2021 | 11.4x | High |
| Q4 2020 | 24.1x | High |
| Q3 2020 | 3.5x | Elevated |
| Q2 2020 | 6.5x | High |
TRIB's net debt is about 12 years of its operating earnings (EBITDA), up from 11 years a year ago.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
TRIB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.6 | Neutral |
| Stochastic | 10.5 | Oversold |
TRIB's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
TRIB PE vs Healthcare Sector
TRIB has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has stronger trend alignment. OSCR is above 5 of 5 weekly averages versus TRIB above 0 of 3.
TRIB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.56 | 10% below |
| 20 week MA | $8.71 | 32% below |
| 50 week MA | $16.5 | 64% below |
TRIB is in a downtrend: it's below all three of its weekly moving averages, and 64% below its 50-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over TRIB on returns for 2026, with the stronger performance.
TRIB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $43.8 | $30.0 | -32% |
| 2026 YTD | $30.0 | $5.88 | -80% |
TRIB has finished every year since 2025 lower, and it's down 80% so far in 2026.